Alzheimer Research: Are Scientists Close to Ending a Feared Disease?
Bacteria, diabetes links, vaccines, and gamma light: multiple scientific avenues against Alzheimer's, the world's fifth leading cause of death.
English · Original discussion in Spanish · Published
Alzheimer Research: Are Scientists Close to Ending a Antiestéticared Disease?
Are we finally witnessing the beginning of the end for one of the most antiestéticared illnesses? Alzheimer’s remains the fifth leading cause of death globally and a medical enigma, yet researchers are accumulating clues that could change the prognosis if they hold up. The latest breakthrough involves the oral microbiome.
The Mouth: A Gateway to the Brain
A study by Cortexyme, published in Science Advances, found gingipains (enzymes from the bacterium Porphyromonas gingivalis) in 96% of 54 brain samples from Alzheimer’s patients. The theory suggests the bacteria travel from inflamed gums to the brain, triggering neurodegeneration. While not a new hypothesis, the prevalence data is striking. Proponents argue that rigorous dental hygiene and mouthwashes could prevent the disease. However, critics note that not everyone with poor dental health develops Alzheimer’s, suggesting oral infection is just one factor, not the sole cause.
Is Alzheimer’s Brain Diabetes?
Another school of thought posits that Alzheimer’s is essentially localized insulin resistance in the brain, triggered by high consumption of sugars and refined carbohydrates. Evidence from Nature Neuroscience indicates prediabetes accelerates neuronal aging and cognitive decline. Supporters recommend ketogenic or low-carb diets as prevention. Yet, the food industry and mainstream medicine seem reluctant to embrace this approach.
Vaccines, Lithium, and Flickering Light: The Most Promising Avenues
Recent research has yielded several striking findings:
- Vaccines: An Oxford University study of 430,000 medical records showed that shingles and respiratory syncytial bicho (RSV) vaccines reduced dementia risk by 29% within 18 months. The common factor is the adjuvant that stimulates the immune system.
- Lithium: Harvard researchers identified that lithium deficiency in the brain may be an early event in Alzheimer’s. In mice, supplementation stabilized memory and reduced amyloid plaques.
- Gamma Oscillations: A Cell study demonstrated that stimulating the brain with 40 Hz light and sound (gamma frequency) eliminated amyloid plaques in mice. This sci-fi-like technique could open a non-pharmacological pathway.
- Methylene Blue and Other Compounds: The old dye, used for urinary infections, shows activity against tau protein, a key culprit in Alzheimer’s. The lion’s mane mushroom (Hericium erinaceus) has also been mentioned, as its beta-glucans and hericenones promote neuronal growth.
Unending Skepticism
Despite the promises, recent history is full of false alarms. A Pfizer rheumatoid arthritis drug that reduced Alzheimer’s risk by 64% in 2015 was never commercialized for that purpose. Mouse trials rarely translate to humans. Furthermore, the pharmaceutical industry, according to some cynics, lacks incentives to cure a chronic disease that generates billions in palliative care revenue.
Meanwhile, families watch their loved ones fade away. Perhaps the answer lies in synergizing these approaches: caring for oral health, controlling sugar, getting vaccinated, supplementing with omega-3 and mushrooms, and exposing oneself to flickering lights. Or perhaps not. But if this disease has taught us anything, it is that scientific humility is the first medicine.
Are we finally witnessing the beginning of the end for one of the most antiestéticared illnesses? Alzheimer’s remains the fifth leading cause of death globally and a medical enigma, yet researchers are accumulating clues that could change the prognosis if they hold up. The latest breakthrough involves the oral microbiome.
The Mouth: A Gateway to the Brain
A study by Cortexyme, published in Science Advances, found gingipains (enzymes from the bacterium Porphyromonas gingivalis) in 96% of 54 brain samples from Alzheimer’s patients. The theory suggests the bacteria travel from inflamed gums to the brain, triggering neurodegeneration. While not a new hypothesis, the prevalence data is striking. Proponents argue that rigorous dental hygiene and mouthwashes could prevent the disease. However, critics note that not everyone with poor dental health develops Alzheimer’s, suggesting oral infection is just one factor, not the sole cause.
Is Alzheimer’s Brain Diabetes?
Another school of thought posits that Alzheimer’s is essentially localized insulin resistance in the brain, triggered by high consumption of sugars and refined carbohydrates. Evidence from Nature Neuroscience indicates prediabetes accelerates neuronal aging and cognitive decline. Supporters recommend ketogenic or low-carb diets as prevention. Yet, the food industry and mainstream medicine seem reluctant to embrace this approach.
Vaccines, Lithium, and Flickering Light: The Most Promising Avenues
Recent research has yielded several striking findings:
- Vaccines: An Oxford University study of 430,000 medical records showed that shingles and respiratory syncytial bicho (RSV) vaccines reduced dementia risk by 29% within 18 months. The common factor is the adjuvant that stimulates the immune system.
- Lithium: Harvard researchers identified that lithium deficiency in the brain may be an early event in Alzheimer’s. In mice, supplementation stabilized memory and reduced amyloid plaques.
- Gamma Oscillations: A Cell study demonstrated that stimulating the brain with 40 Hz light and sound (gamma frequency) eliminated amyloid plaques in mice. This sci-fi-like technique could open a non-pharmacological pathway.
- Methylene Blue and Other Compounds: The old dye, used for urinary infections, shows activity against tau protein, a key culprit in Alzheimer’s. The lion’s mane mushroom (Hericium erinaceus) has also been mentioned, as its beta-glucans and hericenones promote neuronal growth.
Unending Skepticism
Despite the promises, recent history is full of false alarms. A Pfizer rheumatoid arthritis drug that reduced Alzheimer’s risk by 64% in 2015 was never commercialized for that purpose. Mouse trials rarely translate to humans. Furthermore, the pharmaceutical industry, according to some cynics, lacks incentives to cure a chronic disease that generates billions in palliative care revenue.
Meanwhile, families watch their loved ones fade away. Perhaps the answer lies in synergizing these approaches: caring for oral health, controlling sugar, getting vaccinated, supplementing with omega-3 and mushrooms, and exposing oneself to flickering lights. Or perhaps not. But if this disease has taught us anything, it is that scientific humility is the first medicine.
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (264 replies).
More summaries
-
The Classical Canon as a Trench: A Thread of Musical Erudition
A forum thread rescues forgotten composers, recordings, and unusual data while discussing the place of the European classical canon.
-
Fisherman dies after failing to cut engine in time
A 66-year-old fisherman fell overboard and his boat drifted away. His wife heard "turn off the engine" but couldn't react. What the case reveals about safety at sea.
-
Spain's De Facto Ban on Brushing: The Administrative Maze
Brushing isn't legally banned in Spain, but complex permits and drone surveillance make it practically impossible. Here is how the system works.
-
Mosques Burn in Tehran: Protests Spark Debate in Iran
Mosque fires in Tehran ignite debate over legitimacy, death toll, and Spain's silence.
-
AI and Collectibles: The New Trend of Personalized Avatars
We analyze the craze for creating collectible figures with AI and the technical barriers users face.
-
Sánchez Behind Bars or Exiled: The Impossible Forecast
No Spanish president has gone to prison since the Civil War. The forecast of Sánchez behind bars or exiled remains alive and divides political analysis.